Copyright
©The Author(s) 2021.
World J Stem Cells. Aug 26, 2021; 13(8): 1030-1048
Published online Aug 26, 2021. doi: 10.4252/wjsc.v13.i8.1030
Published online Aug 26, 2021. doi: 10.4252/wjsc.v13.i8.1030
Ref. | Country | Species | Cell type | Dosage | Route | Cell | Delivery | Microglia | Microglia | Signal | Ischemic |
Source | Timing | Marker | Activation | Pathway | Model | ||||||
Cunningham et al[109], 2020 | United Kingdom | Mice | MSCs | 1.4 × 106 | Sub | BM | 1 h and 24 h | Iba1 | No effect | IL-1α | MCAO |
Narantuya et al[115], 2010 | Japan | Rats | MSCs | NA | IV | BM | NA | ED1/Iba1 | Inhibit | NA | BCAO |
Ishizaka et al[111], 2013 | Japan | Rats | MSCs | 1 × 106 | IA | NA | 1, 4 or 7 d | ED1 | Inhibit | NA | MCAO |
Yamaguchi et al[120], 2018 | Japan | Rats | MSCs | 1 × 106 | IA | Blood | 24 h | Iba1 | Inhibit | NA | MCAO |
Wang et al[119], 2014 | China | Rats | MSCs | 2 × 106 | IV | BM | 3 h | CD45/CD11b | Inhibit | NA | dMCAO |
Wei et al[19], 2012 | America | Rats | MSCs | 1 × 106 | IV | BM | 24 h | Iba1/OX-42 | Inhibit | NA | MCAO |
Nakajima et al[114], 2017 | Japan | Rats | MSCs | 1 × 106 | IV | BM | 0 or 3 h | Iba1/TNF-α/IL6/IL-1β | Inhibit | IL-10 | MCAO |
McGuckin et al[113], 2013 | France | Rats | MSCs | NA | Stereotaxis | UC | NA | ED1/Iba1 | Inhibit | CD200/STAT3 | Ouabain injection |
Li et al[112], 2018 | China | Rats | MSCs | 1 × 106 | IV | BM | 1 h | CD68/Iba1 | Inhibit | IGF-1/BDNF | dMCAO |
Lv et al[108], 2016 | China | Cells | MSCs | NA | NA | BM | NA | TNF-α/IL6/IL-1β | Inhibit | TNF-α/MSCs/GDNF | OGD |
Wang et al[102], 2020 | Germany | Mice | EVs | 2 × 106 | IV | BM | Immediately | CD45/CD11b | Inhibit | NA | MCAO |
Dabrowska et al[99], 2019 | Poland | Rats | EVs | 5 × 105 | IA | BM | 48 h | ED1 | Inhibit | NA | Ouabain injection |
Geng et al[84], 2019 | China | Rats | EVs | NA | NA | Adipose | NA | Iba1, TNF-α, IL-1β | Inhibit | miRNA-126 | MCAO |
Liu et al[87], 2019 | China | Rats | EVs | 5 × 105 | IV | BM | 2 h | Iba1 | Inhibit | NA | MCAO |
Tian et al[91], 2018 | China | Mice | EVs | NA | IV | BM | 12 h | Iba1 | Inhibit | NA | MCAO |
Sheikh et al[117], 2019 | Japan | Rats | MSCs | 3 × 106 | IV | BM | 24 h | ED1/Iba1 | Inhibit | IL-1β/HIF-1α and VEGF | MCAO |
Wang et al[118], 2013 | Japan | Rats | MSCs | 3 × 106 | IV | BM | 24 h | ED1/Iba1/IL-1β/TNF-α/iNOS, MCP-1 | Inhibit | TLR2/CD40/NF-kB | MCAO |
Yoo et al[122], 2013 | South Korea | Rats | MSCs | 5 × 105 | Stereotaxis | BM | 3 days | CD68/Iba1/MCP-1; TNF-α/iNOS/IL-1β | Inhibit | TGF-β1/MCP-1 | MCAO |
Sheikh et al[116], 2011 | Japan | Rats | MSCs | 3 × 106 | IV | BM | 24 h | Iba1/iNOS/Cox-2/IL8/MCP-1 | Inhibit | IL5 and Fractalkine | MCAO |
Feng et al[110], 2020 | China | Mice | MSCs | 1 × 106/20 g | IV | UC | 2 weeks | M1: CD16/32, Iba1; M2: CD206 | Polarization | H3 methylation | LPS |
Yang et al[121], 2020 | China | Rats | MSCs | 1 × 106 | IV | BM | 24 h before | M1: iNOS/Iba1; M2: Arg 1 | Polarization | miR-30a* | MCAO |
Jiang et al[85], 2018 | China | Rats | EVs | NA | IV | Adipose | NA | M1: TNF-α/IL-6/iNOS; M2: IL-4/CD206/IL-10 | Polarization | miR-30d-5p | MCAO |
Li et al[86], 2020 | China | Mice | EVs | NA | IV | UC | NA | M1: iNOS/CD38/ IL-6/TNF-α/CCL-2; M2: Arg 1/CD206 | Polarization | miR-26b-5p | MCAO |
Zhao et al[20], 2020 | China | Rats | EVs | 200 μL | IV | BM | 1 or 14 d | M1: CD16-32/IL-6/IL-1β; M2: CD206/ IL-10 | Polarization | miR-223-3p/ CysLT2R | MCAO |
Zhao et al[21], 2020 | China | Rats | EVs | 200 μL | IV | BM | 2 h | M1: CD86 NOS/IL-12/TNF-α; M2: CD206 /TGF-β/BDNF | Polarization | CysLT2R and ERK1/2 | MCAO |
- Citation: Xin WQ, Wei W, Pan YL, Cui BL, Yang XY, Bähr M, Doeppner TR. Modulating poststroke inflammatory mechanisms: Novel aspects of mesenchymal stem cells, extracellular vesicles and microglia. World J Stem Cells 2021; 13(8): 1030-1048
- URL: https://www.wjgnet.com/1948-0210/full/v13/i8/1030.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v13.i8.1030